SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150

Affiliations

• ¹ Department of rheumatology, Rennes university hospital, university Rennes, Rennes, France. Electronic address: simon.cadiou@chu-rennes.fr.
• ² Department of rheumatology, Rennes university hospital, university Rennes, Rennes, France.
• ³ Department of internal medicine and clinical immunology, Rennes university hospital, university Rennes, Rennes, France.
• ⁴ Department of rheumatology, Rennes university hospital, university Rennes, Rennes, France; Inserm UMR 1241, Inra, Institut NUMECAN (Nutrition Metabolisms and Cancer), university Rennes, 35000 Rennes, France.
• ⁵ Department of internal medicine and clinical immunology, Rennes university hospital, university Rennes, Rennes, France; Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, university Rennes, Rennes, France.